- Location
pirfenidone
"-
Mark Surber Said for IPF Treatment to Be Successful
Jun 13, 2013US-based inhaled medicines provider Genoa Pharmaceuticals in collaboration with McMaster University has demonstrated advantages of the inhaled aerosol pirfenidone (GP-101) in the treatment of pulmonary fibrosis. The findings showed that ...
Tags: Genoa, Mcmaster University
-
Intermune Canada Has Announced The Availability of IPF Therapy
Jan 23, 2013InterMune Canada has announced the availability of idiopathic pulmonary fibrosis (IPF) therapy, Esbriet, in Canada. University of Toronto professor and vice-chair of medicine and University Health Network IPF researcher and consultant ...
Tags: fibrosis therapy, InterMune, medicine
-
Genoa and McMaster Partnered to Characterize in Vivo Advantages and Potential Impact
Jan 17, 2013Genoa Pharmaceuticals and McMaster University have partnered to characterize the in vivo advantages and potential clinical impact of Genoa's inhaled GP-101 (aerosol pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF). ...
Tags: Pharmaceuticals, clinical impact, exploring mechanisms
-
InterMune Has Completed Divestiture of Actimmune to Vidara Therapeutics
Nov 30, 2012InterMune has completed divestiture of Actimmune (interferon gamma-1b) to Vidara Therapeutics, a part of an international specialty pharmaceutical group of companies with operations in Ireland and the US. Gross proceeds from the sale ...
Tags: Actimmune, interferon gamma-1b, esbriet, pirfenidone
-
InterMune Has Signed a Definitive Agreement with Vidara Therapeutics International
Nov 30, 2012InterMune has signed a definitive agreement with Vidara Therapeutics International (Vidara) to sell its rights to Actimmune (interferon gamma-1b) in $55m cash transaction and a two-year royalty stream. Actimmune, a synthesized version of ...
Tags: Actimmune, interferon gamma-1b, Vidara, InterMune
Related Products
-
Hhd Pharm Pirfenidone High Quality Anti-Fibrosis Drug for Health Treatment
-
Supply High Quality Pirfenidone Powder CAS53179-13-8
-
Safe Delivery 99% Anti-Fibrosis Drug API CAS 53179-13-8 Pirfenidone Pfd Powder
-
Anti-Cancer Pirespa Powder CAS 53179-13-8 Pirfenidone
-
Factory 99% Pirfenidone Powder CAS 53179-13-8 Anti-Cancer Pirfenidone
-
API Pirfenidone CAS: 53179-13-8 for Medical Use-Huaren Pharmaceutical
